Carregant...
Implementation of the plasma MYCN/NAGK ratio to detect MYCN amplification in patients with neuroblastoma
Detection of amplification of the MYCN gene is essential for determining optimal treatment and estimating prognosis of patients with neuroblastoma (NB). DNA FISH with neuroblastoma tissues or patient‐derived bone marrow cells is the standard clinical practice for the detection of MYCN amplification....
Guardat en:
| Publicat a: | Mol Oncol |
|---|---|
| Autors principals: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7607162/ https://ncbi.nlm.nih.gov/pubmed/32896084 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12794 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|